Biotech

All Articles

AvenCell bags $112M to flip 'switchable' CAR-Ts in the clinic

.AvenCell Rehabs has safeguarded $112 million in set B funds as the Novo Holdings-backed biotech loo...

China- based biotech plannings ph. 3 after viewing midstage eye records

.China-based Minghui Drug has actually linked its own thyroid eye ailment therapy to a decrease in e...

Sangamo slashes opportunity to market for Fabry gene therapy as FDA accepts to sped up approval deal

.Sangamo Therapies has actually identified a shortcut to market for its own Fabry disease applicant,...

Otsuka's kidney condition medicine boosts UPCR levels in ph. 3 trial

.Otsuka Pharmaceutical's renal condition medicine has struck the primary endpoint of a phase 3 test ...

Roche throws out $120M tau possibility, giving back rights to UCB

.Roche has actually given back the civil liberties to UCB's anti-tau antibody bepranemab, walking aw...

Editas strengthens in vivo approach through $238M Genenvant deal

.Editas Medicines has signed a $238 thousand biobucks deal to combine Genevant Science's lipid nanop...

Combo end results, Vicodin miss as well as outstanding protection

.Tip has actually disclosed stage 3 records on its near-approval ache medication applicant suzetrigi...

Angelini markers $360M biobucks pact for ph. 1 human brain ailment medication

.Italy's Angelini Pharma has signed a $360 million biobucks treaty centered on a period 1-stage brai...

Sage lays off fifty percent of R&ampD team and also agitates C-suite again

.Sage Rehabs' most recent effort to diminish its pipe and workforce will see a third of the biotech'...

With phase 1 record, Mood has an eye on early-stage sac cancer

.Along with its own lead prospect in a stage 3 test for a rare eye cancer cells, Atmosphere Bioscien...